About Maan Pharmaceuticals
Maan Pharmaceuticals is a Healthcare company based in Ahmedabad (India). Pharmaceutical company specializing in de-addiction treatments and global operations. The company has 27 employees. Its Indian entity Maan Pharmaceuticals Ltd reported revenue of ₹102 Cr. Maan Pharmaceuticals offers products and services including Buprenorphine Formulations and Naltrexone Formulations. Its focus areas include Pharmaceuticals, De-Addiction Treatments, Formulations and Manufacturing.
Company details
MAAN Pharmaceuticals Ltd. is recognized as a global pharmaceutical entity that operates across more than 30 markets. It is dedicated to addressing substance abuse through the development of formulations for de-addiction treatments. Innovative technology is utilized to create superior quality products at affordable prices, with a strong emphasis on unmet medical needs. Manufacturing facilities in Mehsana, Gujarat, adhere to WHO-GMP standards and produce various dosage forms. The companys presence is established in the Indian subcontinent and is expanding internationally, focusing on improving patients quality of life.
- Headquarters Ahmedabad, India
- Employees 27
- SectorsHealthcare
- Email••••••••
- Website maanpharma.com
- Legal Name Maan Pharmaceuticals Ltd
- Date of Incorporation 13 May, 1988
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹102 Cr
FY 2025 · -4% YoY
- Net Profit₹14.06 Cr
FY 2025 · 14% margin
- EBITDA₹21.80 Cr
FY 2025 · 21% margin
- Employee Count27
Associated legal entities of Maan Pharmaceuticals
Maan Pharmaceuticals operates through Maan Pharmaceuticals Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Maan Pharmaceuticals Ltd CIN U24231GJ1988PLC010699 | Active | 13 May 1988 | Ahmedabad, Gujarat | ₹102 Cr | 27 | 5 | View details |
Products & Services of Maan Pharmaceuticals
Maan Pharmaceuticals offers a comprehensive portfolio of products and services, including Buprenorphine Formulations and Naltrexone Formulations.
Formulations for substance abuse are developed and offered in various forms.
Formulations addressing de-addiction needs are provided in branded and generic options.
Board of directors of Maan Pharmaceuticals Ltd (Maan Pharmaceuticals)
Maan Pharmaceuticals Ltd is the primary company behind Maan Pharmaceuticals. The board of Maan Pharmaceuticals Ltd currently have 5 directors; the longest-serving is Hemendra Atmaram Patel, appointed in 2011. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hemendra Atmaram Patel DIN 03112149 | Director | 01 Apr 2011 | 15 yrs 7 mo | Maan Pharmaceuticals Ltd |
| Lalbhai Maljibhai Desai DIN 00088897 | Director | 01 May 2013 | 13 yrs 6 mo | Maan Pharmaceuticals Ltd |
| Nilesh Narendrakumar Ranka DIN 06627285 | Director | 10 Jul 2013 | 13 yrs 3 mo | Maan Pharmaceuticals Ltd |
| Anil Hari Bhambhani DIN 09831964 | Director | 30 Sep 2024 | 2 yrs 1 mo | Maan Pharmaceuticals Ltd |
| Vishnu Motibhai Desai DIN 01208246 | Director | 30 Oct 2024 | 2 yrs | Maan Pharmaceuticals Ltd |
Financials of Maan Pharmaceuticals
Figures of Maan Pharmaceuticals Ltd, the primary company behind Maan Pharmaceuticals, for FY 2025. Revenue was ₹102 Cr (-4% year on year). Net profit was ₹14.06 Cr (14% margin). EBITDA was ₹21.80 Cr (21% margin). Revenue has grown at a compounded annual rate of +7% over five years.
- ₹102 CrRevenue · FY 2025 · -4% YoY
- ₹14.06 CrNet profit · 14% margin
- ₹21.80 CrEBITDA · 21% margin
- ₹7.14 CrPaid-up capital
- 27Employees (provident fund records)
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Maan Pharmaceuticals Ltd are on its company page.
Detailed financial statements for Maan Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Maan Pharmaceuticals
Complete news archive for Maan Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maan Pharmaceuticals
Maan Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Maan Pharmaceuticals has 27 employees.
The primary company behind Maan Pharmaceuticals, Maan Pharmaceuticals Ltd, reported revenue of ₹102 Cr for FY 2025, down 4% year on year.
MAAN Pharmaceuticals Ltd. is recognized as a global pharmaceutical entity that operates across more than 30 markets. It is dedicated to addressing substance abuse through the development of formulations for de-addiction treatments. Innovative technology is utilized to create superior quality products at affordable prices, with a strong emphasis on unmet medical needs. Manufacturing facilities in Mehsana, Gujarat, adhere to WHO-GMP standards and produce various dosage forms. The companys presence is established in the Indian subcontinent and is expanding internationally, focusing on improving patients quality of life.
Maan Pharmaceuticals offers Buprenorphine Formulations and Naltrexone Formulations.
Maan Pharmaceuticals operates through Maan Pharmaceuticals Ltd.
The legal entities of Maan Pharmaceuticals currently have 5 directors, including Lalbhai Maljibhai Desai, Hemendra Atmaram Patel, Nilesh Narendrakumar Ranka and others.